2 June 2020 ORYZON to present additional efficacy clinical data from ALICE Phase IIa trial with iadademstat at the 25th Congress of the European Hematology Association
1 June 2020 ORYZON publishes characterization and mechanism of action of vafidemstat, a Phase II clinical stage LSD1 inhibitor, in PLOS ONE
18 May 2020 ORYZON announces enrollment of first patient in ESCAPE: a Phase II clinical trial with vafidemstat in severely ill COVID-19 patients
24 April 2020 ORYZON to initiate ESCAPE: a Phase II clinical trial to test efficacy of vafidemstat in severely ill COVID-19 patients